Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection.
Autorzy:
Ferrari L; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.; Department of Infectious Diseases, Fondazione PTV, University of Rome Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. Ruggiero A; Department of Neurosciences, Biomedicine and Movement Sciences, School of Medicine, University of Verona, Verona, Italy. Stefani C; Department of Neurosciences, Biomedicine and Movement Sciences, School of Medicine, University of Verona, Verona, Italy. Benedetti L; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy. Piermatteo L; Department of Biology, University of Rome Tor Vergata, Rome, Italy. Andreassi E; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy. Caldara F; Department of Infectious Diseases, Fondazione PTV, University of Rome Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. Zace D; Department of Infectious Diseases, Fondazione PTV, University of Rome Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. Pagliari M; Laboratory of Experimental Animal Models, Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale Delle Venezie, Legnaro, Italy. Ceccherini-SilbersteinF; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy. Jones C; Department of Primary Care and Public Health, Brighton and Sussex Medical School, Falmer, UK. Iannetta M; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.; Department of Infectious Diseases, Fondazione PTV, University of Rome Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. Geretti AM; Department of Infectious Diseases, Fondazione PTV, University of Rome Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. anna_.; Department of Infection, North Middlesex University Hospital, London, UK. anna_.; School of Immunity & Microbial Sciences, King's College London, London, UK. anna_.
Recommendations on data sharing in HIV drug resistance research.
Autorzy:
Inzaule SC; Amsterdam Institute for Global Health and Development, and Department of Global Health, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Siedner MJ; Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America. Little SJ; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, California, United States of America. Avila-Rios S; Centre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico. Ayitewala A; National Health Laboratories and Diagnostic Services, Ministries of Health, Kampala, Uganda. Bosch RJ; Center for Biostatistics in AIDS Research, Harvard TH Chan School of Public Health, Boston, Massachusetts, United States of America. Calvez V; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, Paris, France. Ceccherini-SilbersteinF; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy. Charpentier C; Service de Virologie, Université Paris Cité, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, F-75018 Paris, France. Descamps D; Service de Virologie, Université Paris Cité, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, F-75018 Paris, France. Eshleman SH; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America. Fokam J; Virology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon, and Faculty of Health Sciences, University of Buea, Yaoundé, Cameroon. Frenkel LM; Department of Pediatrics, University of Washington, Seattle, Washington, United States of America. Gupta RK; Cambridge Institute of Therapeutic Immunology and Infectious Diseases, University of Cambridge, Cambridge, United Kingdom. Ioannidis JPA; Department of Medicine, Department of Epidemiology and Population Health, and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, United States of America. Kaleebu P; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Entebbe, Uganda. Kantor R; Department of Medicine, Brown University, The Miriam Hospital, Providence, Rhode Island, United States of America. Kassaye SG; Department of Medicine, Division of Infectious Diseases, Georgetown University, Washington DC, United States of America. Kosakovsky Pond SL; Institute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, Pennsylvania, United States of America. Kouamou V; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe. Kouyos RD; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland and Institute of Medical Virology, University of Zurich, Zurich, Switzerland. Kuritzkes DR; Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America. Lessells R; Affiliation is KwaZulu-Natal Research Innovation & Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa. Marcelin AG; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Laboratoire de Virologie, Paris, France. Mbuagbaw L; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada. Minalga B; Office of HIV/AIDS Network Coordination, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America. Ndembi N; Institute of Human Virology Nigeria, Herbert Macaulay Way, Abuja, Nigeria. Neher RA; Biozentrum, University of Basel, Basel, Switzerland. Paredes R; Department of Infectious Diseases & irsiCaixa, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain. Pillay D; Division of Infection and Immunity, University College London, London, United Kingdom. Raizes EG; United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Rhee SY; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, California, United States of America. Richman DD; Center for AIDS Research, Department of Medicine, University of California San Diego, San Diego, California, United States of America. Ruxrungtham K; School of Global Health, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Sabeti PC; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America. Schapiro JM; National Hemophilia Center, Sheba Medical Center, Ramat Gan, Israel. Sirivichayakul S; Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Steegen K; Department of Molecular Medicine and Haematology, National Health Laboratory Service, Johannesburg, South Africa. Sugiura W; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan. van Zyl GU; Division of Medical Virology, Stellenbosch University and National Health Laboratory Service, Cape Town, South Africa. Vandamme AM; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Leuven, Belgium.; Center for Global Health And Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal. Wensing AMJ; University Medical Center Utrecht, the Netherlands and Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa. Wertheim JO; Department of Medicine, University of California San Diego, San Diego, La Jolla, California, United States of America. Gunthard HF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland and Institute of Medical Virology, University of Zurich, Zurich, Switzerland. Jordan MR; Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America. Shafer RW; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, California, United States of America.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2023 Sep 22; Vol. 20 (9), pp. e1004293. Date of Electronic Publication: 2023 Sep 22 (Print Publication: 2023).
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients.
Autorzy:
Gratteri C; Dipartimento di Scienze della Salute, Campus 'S. Venuta', Università degli Studi 'Magna Græcia' di Catanzaro, Viale Europa, 88100 Catanzaro, Italy. Ambrosio FA; Dipartimento di Medicina Sperimentale e Clinica, Campus 'S. Venuta', Università degli Studi 'Magna Græcia' di Catanzaro, Viale Europa, 88100 Catanzaro, Italy. Lupia A; Dipartimento di Scienze della vita e dell'ambiente, Università degli Studi di Cagliari, Cittadella Universitaria di Monserrato, 09124 Cagliari, Italy.; Net4Science S.r.l., Università degli Studi 'Magna Græcia' di Catanzaro, 88100 Catanzaro, Italy. Moraca F; Net4Science S.r.l., Università degli Studi 'Magna Græcia' di Catanzaro, 88100 Catanzaro, Italy.; Dipartimento di Farmacia, Università degli Studi di Napoli 'Federico II', Via D. Montesano 49, 80131 Napoli, Italy. Catalanotti B; Dipartimento di Farmacia, Università degli Studi di Napoli 'Federico II', Via D. Montesano 49, 80131 Napoli, Italy. Costa G; Dipartimento di Scienze della Salute, Campus 'S. Venuta', Università degli Studi 'Magna Græcia' di Catanzaro, Viale Europa, 88100 Catanzaro, Italy.; Net4Science S.r.l., Università degli Studi 'Magna Græcia' di Catanzaro, 88100 Catanzaro, Italy. Bellocchi M; Dipartimento di Medicina Sperimentale, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy. Carioti L; Dipartimento di Medicina Sperimentale, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy. Salpini R; Dipartimento di Medicina Sperimentale, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy. Ceccherini-SilbersteinF; Dipartimento di Medicina Sperimentale, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy. Frazia S; Dipartimento di Biologia, Università Tor Vergata di Roma, Via della Ricerca Scientifica, 1, 00133 Roma, Italy. Malagnino V; Dipartimento di Medicina dei Sistemi, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy. Sarmati L; Dipartimento di Medicina dei Sistemi, Università Tor Vergata di Roma, Via Montpellier, 1, 00133 Roma, Italy. Svicher V; Dipartimento di Biologia, Università Tor Vergata di Roma, Via della Ricerca Scientifica, 1, 00133 Roma, Italy. Bryant S; Inte:Ligand GmbH, Mariahilferstrasse 74B/11, 1070 Vienna, Austria. Artese A; Dipartimento di Scienze della Salute, Campus 'S. Venuta', Università degli Studi 'Magna Græcia' di Catanzaro, Viale Europa, 88100 Catanzaro, Italy.; Net4Science S.r.l., Università degli Studi 'Magna Græcia' di Catanzaro, 88100 Catanzaro, Italy. Alcaro S; Dipartimento di Scienze della Salute, Campus 'S. Venuta', Università degli Studi 'Magna Græcia' di Catanzaro, Viale Europa, 88100 Catanzaro, Italy.; Net4Science S.r.l., Università degli Studi 'Magna Græcia' di Catanzaro, 88100 Catanzaro, Italy.
Frequency of Atypical Mutations in the Spike Glycoprotein in SARS-CoV-2 Circulating from July 2020 to July 2022 in Central Italy: A Refined Analysis by Next Generation Sequencing.
Autorzy:
Bellocchi MC; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. Scutari R; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy. Carioti L; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. Iannetta M; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. Marchegiani G; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. Piermatteo L; Department of Biology, University of Rome Tor Vergata, 00133 Rome, Italy. Coppola L; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. Tedde S; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. Duca L; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. Malagnino V; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. Ansaldo L; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. Braccialarghe N; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. D Anna S; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. Santoro MM; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. Di Lorenzo A; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. Salpini R; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. Teti E; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. Svicher V; Department of Biology, University of Rome Tor Vergata, 00133 Rome, Italy. Andreoni M; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. Sarmati L; Infectious Disease Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. Ceccherini-SilbersteinF; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. On Behalf Of The Ptv-Utv-Id-Covid Group
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Aug 09; Vol. 15 (8). Date of Electronic Publication: 2023 Aug 09.
Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens.
Autorzy:
Fokam J; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Messa, Yaoundé P.O. Box 3077, Cameroon.; Faculty of Medicine and Biomedical Sciences (FMBS), University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon.; National HIV Drug Resistance Working Group (HIVDRWG), Ministry of Public Health, Yaoundé P.O. Box 3038, Cameroon.; Faculty of Health Sciences, University of Buea, Buea P.O. Box 063, Cameroon. Chenwi CA; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Messa, Yaoundé P.O. Box 3077, Cameroon.; Faculty of Medicine and Biomedical Sciences (FMBS), University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon.; Department of Experimental Medicine, Faculty of Medicine and Surgery, University of Rome 'Tor Vergata', Via Montpellier 1, 00133 Rome, Italy. Takou D; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Messa, Yaoundé P.O. Box 3077, Cameroon. Santoro MM; Department of Experimental Medicine, Faculty of Medicine and Surgery, University of Rome 'Tor Vergata', Via Montpellier 1, 00133 Rome, Italy. Tala V; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Messa, Yaoundé P.O. Box 3077, Cameroon.; Faculty of Medicine and Biomedical Sciences (FMBS), University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon. Teto G; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Messa, Yaoundé P.O. Box 3077, Cameroon. Beloumou G; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Messa, Yaoundé P.O. Box 3077, Cameroon. Semengue ENJ; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Messa, Yaoundé P.O. Box 3077, Cameroon.; Department of Experimental Medicine, Faculty of Medicine and Surgery, University of Rome 'Tor Vergata', Via Montpellier 1, 00133 Rome, Italy. Dambaya B; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Messa, Yaoundé P.O. Box 3077, Cameroon. Djupsa S; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Messa, Yaoundé P.O. Box 3077, Cameroon. Kembou E; World Health Organisation, Country Office, Yaoundé P.O. Box 155, Cameroon. Bouba NP; Department of Disease, Epidemic and Pandemic Control, Ministry of Public Health, Yaoundé P.O. Box 3038, Cameroon. Ajeh R; Central Technical Group, National AIDS Control Committee, Yaoundé P.O. Box 2005, Cameroon. Cappelli G; Italian National Research Council, P. le Aldo Moro, 7, 00185 Rome, Italy. Mbanya D; Faculty of Medicine and Biomedical Sciences (FMBS), University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon.; National Blood Transfusion Service, Ministry of Public Health, Yaoundé P.O. Box 3038, Cameroon.; Haematology and Transfusion Service, Centre Hospitalier et Universitaire (CHU), Yaounde-13, Yaoundé P.O Box 30335, Cameroon. Colizzi V; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Messa, Yaoundé P.O. Box 3077, Cameroon.; Department of Experimental Medicine, Faculty of Medicine and Surgery, University of Rome 'Tor Vergata', Via Montpellier 1, 00133 Rome, Italy. Ceccherini-SilbersteinF; Department of Experimental Medicine, Faculty of Medicine and Surgery, University of Rome 'Tor Vergata', Via Montpellier 1, 00133 Rome, Italy. Perno CF; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Messa, Yaoundé P.O. Box 3077, Cameroon.; Bambino Gesu' Children's Research Hospital, Piazza S. Onofrio 4, 00165 Rome, Italy. Ndjolo A; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Messa, Yaoundé P.O. Box 3077, Cameroon.; Faculty of Medicine and Biomedical Sciences (FMBS), University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Aug 02; Vol. 15 (8). Date of Electronic Publication: 2023 Aug 02.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
